---
layout: splash
title: 휴젤 (145020)
excerpt: 휴젤의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
keywords: 휴젤, 145020
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 207,500 | <span style="color: cornflowerblue">-1.2<small>%</small></span> | Q:제약 | 25.2 | 3.0 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 기초 의약물질 및 생물학적 제제 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 보툴리눔톡신, 필러 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 2015년 12월 24일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 한선호, 문형진 (각자 대표집행임원) |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.hugel.co.kr](http://www.hugel.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 05&#x2011;16 | | [신탁계약에의한취득상황보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240516001524){:target="_blank"} |
|  | | [신탁계약해지결과보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240516001492){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![145020](/stock/images/145020.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 207,500 | <span style="color: cornflowerblue">-1.2<small>%</small></span> | <span style="color: tomato">4.8<small>%</small></span> | <span style="color: cornflowerblue">-0.7<small>%</small></span> | <span style="color: tomato">15.5<small>%</small></span> | <span style="color: tomato">31.6<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">85.0<small>%</small></span> | 45.4<small>%</small> | 1.87 | -15.5<small>%</small> | -4.5<small>%</small> | -5.5 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | 25.2 | 3.0 | - | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/145020/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=145020){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A145020&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=145020){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/145020){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/145020/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![145020](/stock/images/145020_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 85.0<small>%</small> | 45.4<small>%</small> | 1.87 | -15.5<small>%</small> | -4.5<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 47.6<small>%</small> | 44.8<small>%</small> | 1.06 | -17.0<small>%</small> | -5.8<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 2.8<small>%</small> | 30.8<small>%</small> | 0.09 | -27.6<small>%</small> | -14.5<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -8.0<small>%</small> | 33.0<small>%</small> | -0.24 | -30.3<small>%</small> | -16.5<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -14.1<small>%</small> | 34.8<small>%</small> | -0.41 | -22.4<small>%</small> | -13.1<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 44.9<small>%</small> | 39.2<small>%</small> | 1.15 | -15.5<small>%</small> | -4.5<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 48.9<small>%</small> | 36.0<small>%</small> | 1.36 | -15.5<small>%</small> | -3.9<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 57.3<small>%</small> | 35.4<small>%</small> | 1.62 | -15.5<small>%</small> | -3.3<small>%</small> |
| MACD[^fn_tech_metric_macd] | -13.3<small>%</small> | 30.3<small>%</small> | -0.44 | -25.1<small>%</small> | -14.8<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![145020](/stock/images/145020_corr.png){: .align-center}

|       | [알테오젠](/196170/) | [삼성카드](/029780/) | [HD현대일렉트릭](/267260/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [JB금융지주](/175330/) | [메리츠금융지주](/138040/) | [기업은행](/024110/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![145020](/stock/images/145020_2x.png){: .align-center}


> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}